Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Bello Akintunde Olatokumbo — Xilio Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Bello Akintunde Olatokumbo

Bello Akintunde Olatokumbo

Director at Xilio Therapeutics, Inc. · on record since Jun 12, 2026

Insider trading activity of Bello Akintunde Olatokumbo

Transactions on record: 2; since Jun 12, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 12, 2026

Figures computed from official regulatory filings — methodology.

Companies where Bello Akintunde Olatokumbo has traded

Xilio Therapeutics, Inc.2 tx · Jun 12, 2026

Track record of Bello Akintunde Olatokumbo

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Bello Akintunde Olatokumbo

Co-insiders of Bello Akintunde Olatokumbo

Alexandria Venture Investments, LLCXilio Therapeutics, Inc.
Atlas Venture Associates Opportunity I, LLCXilio Therapeutics, Inc.
Atlas Venture Associates Opportunity I, L.P.Xilio Therapeutics, Inc.
Atlas Venture Associates XI, LLCXilio Therapeutics, Inc.
Atlas Venture Associates XI, L.P.Xilio Therapeutics, Inc.
Atlas Venture Fund XI, L.P.Xilio Therapeutics, Inc.
Atlas Venture Opportunity Fund I, L.P.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Xilio Therapeutics, Inc.

Bain Capital Life Sciences Fund II, L.P.Xilio Therapeutics, Inc.

Bain Capital Life Sciences Investors II, LLCXilio Therapeutics, Inc.

Bain Capital Life Sciences Investors, LLCXilio Therapeutics, Inc.

BAY CITY CAPITAL LLCXilio Therapeutics, Inc.

BCIP Life Sciences Associates, LPXilio Therapeutics, Inc.

BCLS II Investco, LPXilio Therapeutics, Inc.

BCLS II Investo (GP), LLCXilio Therapeutics, Inc.

Blanchard Cheryl RXilio Therapeutics, Inc.

Bonstein SaraXilio Therapeutics, Inc.

Brennan AoifeXilio Therapeutics, Inc.

Brennan Kevin M.Xilio Therapeutics, Inc.

Chudnovsky YekaterinaXilio Therapeutics, Inc.

CLACKSON TIMOTHY PXilio Therapeutics, Inc.

Clancy Paul JXilio Therapeutics, Inc.

Curran Daniel J.Xilio Therapeutics, Inc.

English Edward CXilio Therapeutics, Inc.

Estate of Ulrich RodeckXilio Therapeutics, Inc.

FIL LtdXilio Therapeutics, Inc.

FMR LLCXilio Therapeutics, Inc.

Four Pines Master Fund LPXilio Therapeutics, Inc.

Frankenfield Christopher JamesXilio Therapeutics, Inc.

GILEAD SCIENCES INCXilio Therapeutics, Inc.

Giovine SalvatoreXilio Therapeutics, Inc.

GKCC, LLCXilio Therapeutics, Inc.

Heyman Tomas J.Xilio Therapeutics, Inc.

Huber Martin H. Jr.Xilio Therapeutics, Inc.

HUMPHREY RACHELXilio Therapeutics, Inc.

Luptakova KatarinaXilio Therapeutics, Inc.

LYNCH DANIELXilio Therapeutics, Inc.

Merck KGaAXilio Therapeutics, Inc.

RiverVest Venture Fund IV, L.P.Xilio Therapeutics, Inc.

Rock Springs Capital LLCXilio Therapeutics, Inc.

Rock Springs Capital Management LPXilio Therapeutics, Inc.

Rock Springs Capital Master Fund LPXilio Therapeutics, Inc.

Rossi ChristinaXilio Therapeutics, Inc.

ROSS MICHAEL JAYXilio Therapeutics, Inc.

ROSS ROBERT W.Xilio Therapeutics, Inc.

Russo ReneXilio Therapeutics, Inc.

Shannon James SamuelXilio Therapeutics, Inc.

SV7 (IMF) GP LLPXilio Therapeutics, Inc.

SV7 Impact Medicine Fund LPXilio Therapeutics, Inc.

TAKEDA PHARMACEUTICAL CO LTDXilio Therapeutics, Inc.

Takeda Ventures, Inc.Xilio Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Xilio Therapeutics, Inc.	Jun 12, 2026	AwardD	5,000	0.00 USD	$0	SEC
Xilio Therapeutics, Inc.	Jun 12, 2025	AwardD	62,000	0.00 USD	$0	SEC